Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

89.94 -4.45 (-4.71%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 20, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	11,137,120
Open	90.14
Bid (Size)	89.81 (500)
Ask (Size)	90.41 (200)
Prev. Close	94.39
Today's Range	89.17 - 91.11
52wk Range	61.24 - 96.51
Shares Outstanding	N/A
Dividend Yield	1.15%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing

Today 10:32 EST

LONDON — January 20, 2026 — In a milestone moment for global capital markets, pharmaceutical giant AstraZeneca (NYSE: AZN) has officially filed its formal notice of voluntary withdrawal from the Nasdaq...

Via MarketMinute

AstraZeneca PLC (NASDAQ:AZN) Emerges as a Quality Investment Candidate ↗

Today 5:11 EST

Via Chartmill

Performance

YTD	-1.8%	-1.8%
1 Month	-1.8%	-1.8%
3 Month	+7.2%	+7.2%
6 Month	+30.9%	+30.9%
1 Year	+32.3%	+32.3%

More News

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗

January 19, 2026

Via MarketBeat

Why Did EBS Stock Fall 13% Today? ↗

January 15, 2026

Via Stocktwits

AstraZeneca Buys Boston-Based Startup In Fresh AI Push For Cancer Pipeline ↗

January 13, 2026

Via Stocktwits

The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company) ↗

January 15, 2026

Via The Motley Fool

Records, Subpoenas, and $4,600 Gold ↗

January 13, 2026

Via Chartmill

Retail’s Tech Coronation: Walmart Joins the Nasdaq-100 Following Historic Exchange Pivot

January 12, 2026

Via MarketMinute

Walmart (WMT) Hits All-Time High as Investors Pivot to Consumer Defensive Giants

January 12, 2026

Via MarketMinute

Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge

January 09, 2026

Via MarketMinute

AMD Ignites the ‘Yotta-Scale’ Era: Unveiling the Instinct MI400 and Helios AI Infrastructure at CES 2026

January 08, 2026

Via TokenRing AI

Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit

January 08, 2026

From AstraZeneca

Via Business Wire

Momentum in Healthcare and Banking to Persist in 2026 as AstraZeneca and Citigroup Lead the Charge

January 02, 2026

Via MarketMinute

The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls

January 02, 2026

Via MarketMinute

Is IonQ Stock a Buy Now? ↗

December 30, 2025

Via The Motley Fool

The Motley Fool Interviews MichaelAaron Flicker: Hacking the Human Mind ↗

December 29, 2025

Via The Motley Fool

AstraZeneca (NASDAQ:AZN) Shows Strong Technical Setup for Potential Breakout ↗

December 23, 2025

Via Chartmill

The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth

December 22, 2025

Via PredictStreet

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer

December 22, 2025

From AstraZeneca

Via Business Wire

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

December 19, 2025

Via Stocktwits

3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗

December 18, 2025

Via The Motley Fool

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗

December 17, 2025

Via Stocktwits

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer

December 15, 2025

From AstraZeneca

Via Business Wire

What to Watch With IonQ Stock in 2026 ↗

December 11, 2025

Via The Motley Fool

AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH

December 04, 2025

From AstraZeneca

Via Business Wire

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?

Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.

What exchange does AstraZeneca PLC - American Depositary Shares trade on?

AstraZeneca PLC - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?

The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the Nasdaq Stock Market

What is the current price of AstraZeneca PLC - American Depositary Shares?

The current price of AstraZeneca PLC - American Depositary Shares is 89.94

When was AstraZeneca PLC - American Depositary Shares last traded?

The last trade of AstraZeneca PLC - American Depositary Shares was at 01/20/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.